期刊论文详细信息
Cells
Interneuron Dysfunction and Inhibitory Deficits in Autism and Fragile X Syndrome
Toshihiro Nomura1 
[1] Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA;
关键词: autism;    fragile X syndrome;    interneuron;    GABA;    E–I balance;   
DOI  :  10.3390/cells10102610
来源: DOAJ
【 摘 要 】

The alteration of excitatory–inhibitory (E–I) balance has been implicated in various neurological and psychiatric diseases, including autism spectrum disorder (ASD). Fragile X syndrome (FXS) is a single-gene disorder that is the most common known cause of ASD. Understanding the molecular and physiological features of FXS is thought to enhance our knowledge of the pathophysiology of ASD. Accumulated evidence implicates deficits in the inhibitory circuits in FXS that tips E–I balance toward excitation. Deficits in interneurons, the main source of an inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), have been reported in FXS, including a reduced number of cells, reduction in intrinsic cellular excitability, or weaker synaptic connectivity. Manipulating the interneuron activity ameliorated the symptoms in the FXS mouse model, which makes it reasonable to conceptualize FXS as an interneuronopathy. While it is still poorly understood how the developmental profiles of the inhibitory circuit go awry in FXS, recent works have uncovered several developmental alterations in the functional properties of interneurons. Correcting disrupted E–I balance by potentiating the inhibitory circuit by targeting interneurons may have a therapeutic potential in FXS. I will review the recent evidence about the inhibitory alterations and interneuron dysfunction in ASD and FXS and will discuss the future directions of this field.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次